Genotoxic carcinogens exert their tumorigenic effects in part by inducing genomic instability. We recently showed that loss of heterozygosity (LOH) on chromosome 12 associates significantly with the induction of chromosome instability (CIN) by the likely human lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and vinyl carbamate (VC) during mouse lung carcinogenesis. Here, we demonstrate the carcinogen specificity of this event and its effect on lung tumor evolution. LOH on chromosome 12 was observed in 45% of NNK-induced, 59% of VC-induced, 58% of aflatoxin B1 (AFB1)-induced, 14% of N-ethyl-N-nitrosourea (ENU)-induced and 12% of spontaneous lung adenocarcinomas. The frequency of LOH in each of the carcinogen-induced groups, except ENU, was significantly higher than in the spontaneous group (Po0.001). Deletion mapping revealed four potential candidate regions of 1-4 centiMorgans suspected to contain targeted tumor suppressor genes, with at least one expected to have a role in CIN. The relationship between LOH on chromosome 12 and additional chromosomal alterations occurring during lung tumor progression was also examined. LOH on chromosomes 1 and 14 were moderately frequent during malignant progression in tumors from all treatment groups, occurring in 21-35 and 18-33% of tumors. However, these alterations showed significant concurrence with LOH on chromosome 12 in VC-, NNK-and AFB1-induced tumors (Po0.05). The results suggest that a carcinogen-selective mechanism of lung cancer induction involves the frequent inactivation of genes on chromosome 12, including a stability gene that evidently promotes the evolutionary selection of additional chromosomal alterations during malignant progression.
Introduction
Tumor cells typically have unstable genomes resulting from defects in the fidelity of DNA replication, damage repair, chromosome segregation or telomere maintenance (Cheng and Loeb, 1997; Lengauer et al., 1998; Breivik and Gaudernack, 1999) . The increased mutation rate accompanying genomic instability is conceivably a continued source of genetic variation from which changes advantageous for tumor evolution may be selected (Loeb, 1998) . Chromosome instability (CIN) is a type of genomic instability characterized by an increased rate of occurrence of abnormal chromosome number and structure, and is typical of most solid tumor types, including those of the lung (Masuda and Takahashi, 2002; Gisselsson, 2003) . Microsatellite instability (MIN) is a type of genomic instability characterized by an increase in mismatch mutations caused by defects in mismatch repair function; CIN by comparison is complex in phenotype (Hoeijmakers, 2001; Jallepalli and Lengauer, 2001) . Many different genes/functions have been associated with both CIN and cancer predisposition. For example, germline mutations of genes for DNA repair (e.g. XPD, BRCA2 and RAD51), cell cycle checkpoint regulation (e.g. ATM) and chromosome segregation (e.g. MAD2) predispose to cancers characterized by CIN (Bishop et al., 2000; Lehmann, 2001; Michel et al., 2001; Powell et al., 2002) . As the causes of CIN seem to be diverse, the somatic mutations leading to CIN in sporadic cancers may be dispersed among many genes instead of relatively few.
DNA-damaging agents are likely to induce CIN by exerting selective pressure on cellular responses to the DNA damage they cause (Breivik, 2001 ). This may target certain 'caretaker' genes/functions for alterations in the induction of cancer. Studies indeed have shown that germline mutations of certain caretaker genes, such as genes for radiation-induced DNA double strand break repair (RAD51) and xeroderma pigmentosum complementation group A (XPA), increase sensitivity to particular DNA-damaging agents, genomic instability and cancer. It is therefore likely that selective pressure on these or other stability genes contributes to the somatic induction of cancer (de Vries, 1995; Hoeijmakers, 2001; Powell et al., 2002) .
Genotoxic carcinogens present in cigarette smoke are known causes of lung cancer and may exert their tumorigenic effect by inducing CIN. Polycyclic aromatic hydrocarbons and tobacco-specific nitrosamines are two major classes of genotoxic lung carcinogens (Dipple, 1995; Hecht, 1999) . Benzo(a)pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) are representative of these two classes, respectively (Dipple, 1995; Hecht, 1999) . Mouse models have demonstrated that these and various other environmental carcinogens, such as urethane and N-ethyl-N-nitrosourea (ENU), are potent mutagens and lung carcinogens (Anderson, 1978; Hecht et al., 1978; Branstetter et al., 1987) . Molecular studies of lung carcinogenesis in mice also have demonstrated that these lung carcinogens cause mutations in key lung cancer genes, such as p53 and Kras (Herzog et al., 1997; Tam et al., 1999) . However, numerous other genetic changes are common in human and mouse lung carcinogenesis for which the role of carcinogens is largely undefined (Minna, 1993; Hegi et al., 1994; Herzog et al., 1996; Osada and Takahashi, 2002) .
We previously showed that NNK and vinyl carbamate (VC), lung carcinogens with distinct genotoxic characteristics, induced extensive CIN during mouse lung carcinogenesis compared to spontaneous tumors in mice (Herzog et al., 2002) . The carcinogen-induced tumors also displayed unique profiles of global loss of heterozygosity (LOH), in which tumors induced with VC and NNK displayed frequent LOH on chromosome 12 in association with the CIN phenotype. This indicated that carcinogen-specific selective pressures directly influenced the development of these tumors by targeting chromosome 12. Here we investigated the carcinogen specificity of chromosome 12 targeting in CIN and lung carcinogenesis, and its effect on evolutionary genetic changes during lung tumor progression.
Results
We previously demonstrated that chromosomes 1, 4, 12 and 14 were relatively frequent sites of LOH in the malignant progression of mouse lung adenocarcinomas (Herzog et al., 1996) . Unique among these, chromosome 12 was shown to occur in lung tumors induced by carcinogens (VC and NNK), but not in spontaneous tumors. As a potential biomarker for carcinogeninduced lung cancer, we therefore investigated the carcinogen specificity of LOH on chromosome 12 in lung adenocarcinomas. For this purpose NNK, VC, aflatoxin B1 (AFB1) and ENU, all of which induce DNA damage by different mechanisms, were used to induce lung tumors. LOH on chromosome 12 occurred at a frequency of 39/67 (58%) in AFB1-induced, 15/33 (45%) in NNK-induced, 22/37 (59%) in VC-induced, 6/ 43 (14%) in ENU-induced and 3/26 (12%) in spontaneous tumors (Table 1) . LOH was significantly more frequent in the AFBI-, NNK-and VC-induced tumors compared to the spontaneous tumors (Po0.001). In contrast, ENU did not induce LOH on this chromosome.
An examination of 206 lung adenocarcinomas has placed the targeted gene between D12MIT170 and D12MIT233, located 6 and 47 centiMorgans (cM) from the centromere, respectively. D12MIT233 is located 10 cM from the telomere and losses here occurred in 89% of the tumors with LOH on this chromosome (Figure 1 ). D12MIT233 was the exclusive target of LOH in 14 tumors. D12MIT170 incurred losses in 84% of tumors with LOH, and was the exclusive target in nine tumors (Figure 1 ). In most of the cases, losses appeared to be large, encompassing both D12MIT170 and D12MIT233, indicating that the main mechanisms of LOH involved much of chromosome 12.
An unexpected lack of informative markers between D12MIT170 and D12MIT233 limited our efforts to map the position(s) of the target gene(s) in these tumors. However, tumor-derived cell lines, which possess genetic alterations consistent with those detected in primary tumors, were used for this purpose. Four separate regions of focused deletion were fine mapped on chromosome 12 using eight clonally expanded cell lines derived from A/J mouse lung adenocarcinomas (Figure 2 , see Materials and methods for a description of deletion analysis). Frequently deleted loci were centered at D12MIT213-D12MIT52 (23-27 cM from centromere), D12MIT157-D12MIT214 (32-33 cM), D12MIT233 (47 M) and D12MIT96 (57 cM). Among these loci, D12MIT213-D12MIT52 and D12MIT96 lost one or both alleles in all eight cell lines examined, compared to D12MIT157 and D12MIT233, which showed losses in six of eight, and five of eight cell lines, respectively. Each of these loci is located within or very near to the broad region of most frequent LOH observed in the lung tumors. Of note, several of the cell lines used were previously shown to possess a CIN phenotype (Sargent et al., 2002) . These results suggest that as many as four tumor suppressor genes may be located on chromosome 12 with significant roles in CINdirected or carcinogen-induced lung cancer.
Allelic variation in the function or expression of cancer genes may be exploited in tumorigenesis. We showed that allelic bias for LOH of chromosome 4 occurred in these mouse lung tumors, in which a functionally diminished haplotype of Ink4a was Chi-square compares the frequencies in carcinogen-induced tumors to the spontaneous tumors (SP). *Po0.001
preferentially retained in tumors, with LOH affecting this locus (Herzog et al., 1999) . We did not observe allelic bias on chromosome 12 as both homologues of chromosome 12 were similarly affected by LOH. Inherent variation between the parental strains was not influential in the targeting of chromosome 12 for LOH ( Figure 1 ). Chromosomes 1 and 14 were also analysed for LOH in these lung tumors (see Materials and methods for markers used). LOH on chromosome 14 was observed in 6/33 (18%) of AFB1-induced, 9/33 (27%) of NNKinduced, 12/36 (33%) of VC-induced, 8/39 (21%) of ENU-induced and 7/26 (27%) spontaneous tumors. LOH on chromosome 1 occurred in 8/33 (24%) of NNK-induced, 13/37 (35%) of VC-induced, 12/41 (21%) of ENU-induced, 5/24 (21%) of AFB1-induced and 6/26 (23%) spontaneous lung tumors. The LOH frequencies were not significantly different on comparing all carcinogen treatment groups to the spontaneous tumor group (Table 1) . Also, both parental homologues Carcinogen-specific LOH on chromosome 12 in mouse lung tumors CR Herzog et al of these chromosomes were affected by LOH with a similar frequency, indicating that allelic variation did not contribute to their occurrence (data not shown).
All of the tumors examined in this study were from C3A and AC3 F1 hybrids, except the ENU-induced tumors, which were obtained from the AB6 and B6A F1 hybrid mice. Our analysis of chromosomes 1 and 14 showed no evidence of strain-specific variation in the frequency of LOH. Also, similar LOH frequencies in lung adenocarcinomas from these different hybrid strains have been reported (25,26). The differences observed here therefore most likely reflect differences in selective pressures exerted by the carcinogens.
Our previous results suggested that a gene on chromosome 12 might be targeted for alteration as a causal factor in the induction of CIN by some carcinogens. As CIN is expected to increase the rate of selection of chromosomal alterations advantageous for tumor progression, we reasoned that LOH targeting this putative gene should frequently occur concomitantly with LOH on chromosome 1 or 14, since they have been found to occur during malignant progression (Table 1; Herzog et al., 1996) . Thus, we first analysed the frequency of LOH on chromosome 1 or 14 in tumors with and without LOH on chromosome 12 in the NNK, VC and AFB1 tumors. The ENU-induced and spontaneous tumors groups were excluded from this analysis because of infrequent chromosome 12 LOH. It was determined that LOH on chromosome 1 or 14 occurred frequently in tumors with LOH on chromosome 12 (Figure 3 ). This association was significant in the NNKinduced tumors and when the carcinogen-induced tumors were combined (Table 2 ). This analysis, however, did not take into account the potential influence of LOH on chromosome 12, as a potential inducer of CIN, on other events that may contribute to tumor progression. Therefore, in order to address specifically whether carcinogen-induced LOH on chromosome 12 is likely to promote LOH on chromosomes 1 and 14, we sorted separately from each treatment group those tumors that had LOH on chromosomes 1 and 14. These tumors were then evaluated for LOH on chromosome 12. The percentage of carcinogen-induced tumors with losses on chromosomes 1 and 12, and 14 and 12 was compared to that of the spontaneous tumors; all except the ENU group showed a significant difference (Table 3) . Allelic losses associated with lung tumor progression occurred significantly more often in tumors with NNK-, AFB1-or VC-induced LOH on chromosome 12.
Discussion
The results from this study demonstrate that specific carcinogens frequently and selectively induce LOH on chromosome 12 during lung carcinogenesis, an event we show to be linked with CIN and tumor progression. We have shown that the carcinogens NNK, VC and AFB1, but not ENU or endogenous factors, targeted chromosome 12 for LOH in lung carcinogenesis. These LOH, in addition to those on chromosomes 1, 4 and 14, were previously shown to occur relatively frequently during the malignant progression of mouse lung adenocarcinomas (Herzog et al., 1996) . K-ras mutations occur at a very high frequency (B90%) in both spontaneous and carcinogen-induced adenomas and precede the emergence of LOH in the progression of lung tumorigenesis in mice (Herzog et al., 1997) . We have examined the role of carcinogenic induction on these later chromosomal events in lung carcinogenesis. Spontaneous tumors were shown to have a very high frequency of allelic deletions on chromosome 4 (77%) compared to NNK-induced tumors (36%) (Herzog et al., 2002) . In contrast, lung adenocarcinomas induced by NNK and VC showed frequent LOH on chromosome 12 compared to spontaneous lung adenocarcinomas. This indicated that endogenous and exogenous factors differentially influenced some key evolutionary changes occurring during the genesis of these tumors. Importantly, this also included the induction of CIN, which was significantly more extensive in the tumors induced by NNK and VC with LOH on chromosome 12.
CIN is common to most cancer types, but its origins are currently unknown (Cheng and Loeb, 1997; Lengauer et al., 1998; Breivik and Gaudernack, 1999; Gisselsson, 2003) . By increasing the rate of genetic selection, CIN may be a critical limiting factor for the rate of tumor evolution. Carcinogens increase the rate of tumorigenesis and may do so via the induction of CIN (Breivik and Gaudernack, 1999) . Our results show that specific chromosomal alterations, which have been Figure 2 Fine mapping of deletions on chromosome 12 in mouse lung adenocarcinomas cell lines. The microsatellite markers are in order relative to the centromere (at top), with the distance of each marker from the centromere shown in cM. Allelic losses were determined relative to A/J mouse lung DNA, as described in the Materials and methods. Black, allelic loss of 460%; dark gray, allelic loss of 40-60%; light gray, allelic loss of 25-40%; white, allelic loss of o25%; ND, not determined shown to associate with the malignant progression of lung tumors, occur significantly more often in tumors with carcinogen-induced LOH on chromosome 12. This demonstrates an association between chromosome 12 targeting and the progression of genetic selection during lung tumorigenesis. In light of our previous findings, the induction of CIN via the carcinogenic targeting of chromosome 12 seems to represent a carcinogen-specific mechanism promoting the selection of chromosomal alterations in the malignant progression of these tumors. This suggests that CIN may indeed potentiate genetic selection in lung carcinogenesis.
The induction of genomic instability by DNAdamaging agents is likely to occur as a consequence of selective pressure exerted on the cellular responses to DNA damage (Breivik and Gaudernack, 1999) . For example, the methylating agents, N-methyl-N-nitrosourea and N-methyl-N 0 -nitrosoguanidine, were shown to induce MIN through selective pressure on mismatch repair function (Branch et al., 1995; Breivik and Gaudernack, 1999; Bardelli et al., 2001) . Analogously, 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine, a bulky adduct forming carcinogen, induced CIN in colon cancer cells (Bardelli et al., 2001) . These findings supported the proposal that carcinogens could induce distinct types of genomic instability based on the type of DNA damage they cause (Breivik and Gaudernack, 1999) . In these cases, genomic instability was coincident with an acquired tolerance to the cytotoxicity of the carcinogens, and suggested that DNA damage-sensing functions that are also networked to apoptotic responses may be selectively abrogated in the carcinogenic induction of genomic instability (Bernstein et al., 2002) . Current results indicate that such functions may indeed be targeted by selective pressure in carcinogeninduced genomic instability (Breivik and Gaudernack, 1999; Breivik, 2001; Hoeijmakers, 2001; Bernstein et al., 2002) .
Our results suggest that NNK, VC and AFB1, but not ENU or endogenous damage, target an unknown caretaker gene on chromosome 12. Such a gene may represent a common cellular response to the DNA damage induced by these carcinogens. Although NNK, Chi-square analysis compares tumors with LOH on chromosome 12 to those without LOH on chromosome 12. NS, not significant VC and AFB1 are diverse in their interactions with DNA, they are distinguished from ENU by their ability to induce oxidative damage and DNA strand breaks, which are expected to cause CIN (Trushin et al., 1994; Shen et al., 1995; Ballering et al., 1997; Sipowicz et al., 1997) . VC reacts with DNA forming etheno adducts that cause point mutations, deletions, homologous recombination and gross chromosomal defects (Ballering et al., 1997). AFB1 forms a major bulky adduct at the N7 position of guanine, and leads to an S and G2 arrest consistent with replication fork stalling, and secondary DNA strand breaks (Ricordy et al., 2002) . NNK pyridyloxobutylation adducts are also relatively bulky and may lead to strand breaks as a consequence of their incomplete repair (Ballering et al., 1997) . In contrast, ENU forms O 6 alkyl guanine adducts that require alkyl guanine alkyl transferase and mismatch repair (Claij et al., 2003) . The DNA damage caused by ENU, unlike these other carcinogens, is more consistent with the induction of MIN rather than CIN. Thus, similarities in DNA damage caused by NNK, VC and AFB1 may account for the targeting of an unidentified gene on midchromosome 12 in the somatic induction of CIN during lung carcinogenesis.
Analysis of several mouse adenocarcinomas and derived cell lines demonstrated that potentially four tumor suppressors genes were inactivated by interstitial allelic loss in lung tumors with CIN. Interestingly, the inactivation of several linked tumor suppressor genes by deletion was similarly implicated on chromosome 3p in human lung cancer (Gerard et al., 2000) . Mouse chromosome 12 contains extensive synteny with human chromosome 14q, which is a site of frequent LOH in non-small-cell lung cancer, particularly in tumors from smokers with more extensive CIN (Wong et al., 2002) . This suggests that the human orthologue(s) of the target gene(s) on mouse chromosome 12 may also contribute to carcinogen-induced CIN in human lung cancer.
Mouse chromosome 12 may also possess genes involved in the inherited susceptibility to urethaneinduced mouse lung carcinogenesis (Pataer et al., 1997; Fijneman et al., 1998) . Together with our data, this implicates the presence of more than one gene on chromosome 12 involved in lung carcinogenesis. Frequent large deletions of this chromosome, such as those observed in the tumors analysed here, may be selected because they efficiently inactivate several genes simultaneously. At least one of these genes is expected to act as a caretaker that is protective against NNK-, AFB1-and VC-induced DNA damage. Based on current evidence, only the D12MIT213-D12MIT52 (23-27 cM) candidate site contains genes (Rad51l and Pole2) with putative caretaker functions consistent with the genotoxicity of NNK, VC and AFB1 and CIN induction. However, further analysis is clearly needed to identify the target genes on this chromosome.
Carcinogenic induction is the major cause of human lung cancer, of which NNK is likely to contribute significantly (Hecht, 1999) . We show that chromosome 12 may harbor a specific biomarker for the induction of lung cancer with NNK. Such a biomarker may prove applicable in strategies for assessing carcinogenic exposure and cancer risk, and in new approaches for the prevention and treatment of lung cancer.
Materials and methods

Lung tumors
C3H/HeJ Â A/J (C3A) and A/J Â C3H/HeJ (AC3) F1 hybrid lung carcinomas either developed in the absence of carcinogenic induction (spontaneous) or were induced by VC, AFB1 or NNK. Tumors were induced with 20 or 60 mg VC/kg body weight by a single i.p. injection at 7 weeks of age. Induction of tumors by NNK was by i.p. injection of 50 mg NNK/kg body weight three times per week for 8 weeks, and by AFB1 by i.p. injection with 6.25 mg/kg three times per week for 8 weeks. Lung adenocarcinomas were induced by ENU in C57BL/ 6J Â A/J (B6A) and A/J Â C57BL/6J (AB6) F1 hybrids. ENU was administered i.p. as a single injection of 100 mg/kg body weight. All of the carcinogen-induced tumors were obtained from 6-to 14-month-old mice. Spontaneous tumors developed after 14 months of age without carcinogenic induction. All of the tumors used were diagnosed by histopathological analysis as adenocarcinomas. Genomic DNA was isolated as previously described (Herzog et al., 1996) .
Lung tumor cell lines
The Spon cell lines and CL20 were grown in RPMI medium containing 2% fetal bovine serum. PCC4 was grown in Minimal Essential medium containing 10% fetal bovine serum. All media were supplemented with 2 mM glutamine, Chi-square analysis compares carcinogen-treated groups to the spontaneous group (SP), except VC+NNK+AFBI is compared to SP+ENU. NS, not significant
Carcinogen-specific LOH on chromosome 12 in mouse lung tumors CR Herzog et al 100 mg/ml penicillin and 100 mg/ml streptomycin. Cells were grown in a humidified incubator at 371C and 5% CO 2 .
Loss of heterozygosity and deletion analyses
Several informative DNA markers on chromosomes 1, 12 and 14 were used to determine LOH frequencies in spontaneous, ENU-, AFB1-, NNK-and VC-induced lung tumors by PCR. These are as follows: D12MIT56, D12MIT104, D12MIT170, D12MIT233, D12MIT280, D12MIT133, D14MIT34, D14MIT78, D14MIT78, D1MIT10, D1MIT285, D1MIT146, D1MIT148 and D1MIT90. Typically, 50-100 ng of tumor or normal lung DNA was PCR amplified as follows: 1 min 951C, 1 min 571C and 30 s 721C for 25 cycles. One primer of each pair was 5 0 end-labeled with 32 P-ATP using T4 polynucleotide kinase prior to PCR. PCR products were then electrophoresed in 8% denaturing polyacrylamide and autoradiographed. In order to identify both clonal and subclonal allelic loss, LOH was scored as a reduction of one of the alleles by X30% relative to the other and normalized against the allelic ratios determined from corresponding normal lung DNA.
A PCR-based deletion analysis of cell lines was performed using the following D12MIT microsatellite markers: 104, 56, 58, 170, 284, 235, 64, 88, 285, 247, 213, 52, 4, 93, 157, 158, 214, 227, 159, 96, 102, 277,233, 280, 133 and 8 . PCR was carried out essentially as described above. Alternatively, unlabeled primers were used and the PCR products were resolved in 2% agarose gels. Allelic deletions were determined by measuring the ratio of target allele/D3MIT64 (control) in the cell lines. These ratios were normalized with those obtained from normal A/J mouse lung DNA. D3MIT64 was selected as a control based on the very infrequent alteration of chromosome 3 in mouse lung tumors and derived cell lines (Herzog et al., 1996; Sargent et al., 2002) . Quantitative PCR used the UVP Imaging and Analysis System and LabWorks software (UVP, Inc., Upland, CA, USA). A reproducible reduction of 25-40% was evidence of subclonal allelic loss. The clonal loss of one allele was a reduction in relative marker intensity by 40-60%, and likely clonal and subclonal homozygous deletions were reductions of greater than 60%.
